Answers are grounded in this paper and cite their sources.
Globally, the incidence of inflammatory bowel disease increased by 47.5% between 1990 and 2019. Biologic medications are often used in moderate-to-severe cases of inflammatory bowel disease. These medications suppress the immune system, placing individuals at increased risk of infections, vitamin deficiencies, and other adverse outcomes. This 12-week quality improvement project evaluated the use of an electronic dashboard to improve rates of health maintenance activities in patients diagnosed with inflammatory bowel disease receiving biologic therapies utilizing a Plan-Do-Study-Act design. Baseline data showed laboratory monitoring at 67%, bone density testing at 46%, tuberculosis screening at 54%, and pneumococcal vaccination at 33%. The rate of influenza vaccination for the previous season was 63%. Postimplementation, increases in rates of all five health maintenance activities were seen, with laboratory monitoring at 96%, bone density testing at 96%, tuberculosis screening at 96%, pneumococcal vaccination at 78%, and influenza vaccination at 78%. The care of patients with inflammatory bowel disease is complex and requires commitment from medical professionals to provide up-to-date care. Electronic dashboards can assist with providing this type of care.
No takes yet. Share an insight, caveat, or question.
Carolyn Gaulke (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: